Market Overview

Benzinga's Top #PreMarket Gainers

Share:
Related DNDN
8-K From Dendron Shows Approval For Order Authorizing Sale Transaction To Valeant
Form 8-K Shows Dendreon Debtors Determined Not To Select Stalking Horse Bid
Related ZGNX
Zogenix Announces New Efficacy Data from Long-Term Study of Low-Dose Fenfluramine for Treatment of Dravet Syndrome
Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study
Zogenix's ZX008 reduces frequency of seizures in severe epilepsy (Seeking Alpha)

Dendreon (NASDAQ: DNDN) surged 16.60% to $2.95 in the pre-market session on reports that the company has hired JP Morgan to help find a buyer.

Zogenix (NASDAQ: ZGNX) shares gained 9.21% to $3.32 in the pre-market session after the company won the FDA approval for Zohydro ER capsules.

Ariad Pharmaceuticals (NASDAQ: ARIA) soared 5.06% to $3.74 in the pre-market trading. ARIAD Pharmaceuticals is expected to report its Q3 financial results on November 6, 2013.

SolarCity (NASDAQ: SCTY) shares jumped 4.14% to $60.43 in pre-market trading. SolarCity's trailing-twelve-month revenue is $125.18 million.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (ARIA + DNDN)

Around the Web, We're Loving...